Sign In
Buy MACK
$15.13
+0 (+0%)
At Close: Aug 19, 2024
CareFirst BlueCross BlueShield Reimagines Weight Management and Diabetes Prevention with Noom
08:00am, Wednesday, 03'rd May 2023
NEW YORK--(BUSINESS WIRE)--Noom for Work, the commercial leader in behavior change, announced today that it would deliver two new preventive health solutions to commercial members of CareFirst BlueCro
Claros Mortgage Trust, Inc. Reports First Quarter 2023 Results
04:24pm, Tuesday, 02'nd May 2023
NEW YORK--(BUSINESS WIRE)--Claros Mortgage Trust, Inc. (NYSE: CMTG) (the “Company” or “CMTG”) today reported its financial results for the quarter ended March 31, 2023. The Company’s first q
Wells Fargo Foundation Awards $7.5 Million to Habitat for Humanity to Build, Repair Homes
09:00am, Tuesday, 02'nd May 2023
DES MOINES, Iowa--(BUSINESS WIRE)--Today, the Wells Fargo Foundation announced a $7.5 million grant to Habitat for Humanity International to help make homes more affordable and accessible for everyone
Virpax Pharmaceuticals Engages Dr. Pardeep Gupta to Assist in Development of Company’s Lead Asset, Probudur™
08:58am, Thursday, 27'th Apr 2023
BERWYN, Pa.--(BUSINESS WIRE)--Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-t
3 Stocks Insiders Are Buying: Triumph Financial And More
11:40am, Wednesday, 01'st Feb 2023 Benzinga
Although US stocks closed higher on Tuesday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stoc
$2.6M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying
11:25am, Wednesday, 18'th Jan 2023 Benzinga
Although US stocks closed mostly lower on Tuesday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view th
Insiders Buying Heska, B. Riley Financial And 2 Other Stocks
11:51am, Tuesday, 10'th Jan 2023 Benzinga
Although US stocks closed mixed on Monday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock
$1.4 Million Bet On Joint Corp? Check Out These 3 Stocks Insiders Are Buying
11:39am, Wednesday, 04'th Jan 2023 Benzinga
Although US stocks closed lower on Tuesday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock
Merrimack Still Has Significant Arbitrage Potential
10:33am, Wednesday, 04'th Jan 2023
In December 2022, MACK got positive clinical results for its Phase III clinical trial of Onivyde in first line pancreatic cancer. A $225m milestone from Ipsen will be triggered on approval, which corr
The Zacks Analyst Blog Highlights Merrimack Pharmaceuticals, Moderna and Seagen
11:56am, Thursday, 17'th Nov 2022 Zacks Investment Research
Highlights Merrimack Pharmaceuticals, Moderna and Seagen are included in this Analyst Blog.
Biotech Stock Roundup: MACK Up on Study Data, MRNA Offers Vaccine Update & More
04:28pm, Wednesday, 16'th Nov 2022 Zacks Investment Research
Pipeline updates from MACK and MRNA are the key highlights from the biotech sector during the past week.
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
10:12am, Thursday, 10'th Nov 2022 Benzinga
Gainers
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares climbed 212.8% to close at $12.51 on Wednesday after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimac
Nasdaq Drops 200 Points; Meta Platforms Shares Jump
07:24pm, Wednesday, 09'th Nov 2022 Benzinga
U.S. stocks traded lower toward the end of trading , with the Nasdaq Composite dropping 200 points on Wednesday.
The Dow traded down 1.44% to 32,684.65 while the NASDAQ fell 1.89% to 10,416.00. The S&
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
05:33pm, Wednesday, 09'th Nov 2022 Benzinga
Gainers
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares jumped 219% to $12.80 after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimack is eligible for up to $
Crude Oil Down Over 2%; Outset Medical Shares Spike Higher
05:19pm, Wednesday, 09'th Nov 2022 Benzinga
U.S. stocks traded lower midway through trading as investors focused on the outcome of the midterm elections.
The Dow traded down 0.64% to 32,950.16 while the NASDAQ fell 0.76% to 10,535.77. The S&P 5
